-
Baxalta (Bax from the name of its
former parent company; alta a
Latin adjective meaning 'high' or 'profound') is a
biopharmaceutical company founded on...
- made its most
significant purchase, with the $32
billion acquisition of
Baxalta (which had been spun-off from
Baxter the
previous year),
creating the largest...
-
Retrieved 2015-12-11. "David M****,
president of
oncology division of
Baxalta".
Baxalta.
Retrieved 2015-07-11. "Ipsen
Names David M**** CEO". Nasdaq. Retrieved...
-
Baxter International Inc. and the bio-pharmaceuticals
company is
named Baxalta and spun-off as a new
public company that
showed on
trading boards as of...
-
becoming CEO of
Baxalta from July 2015, when
Baxalta was spun off by its
parent company,
Baxter International until the
finalization of
Baxalta's acquisition...
- 500" (PDF). www.****e-indices.com. 2015-06-29.
Retrieved 2015-06-29. "
Baxalta to Join the S&P 500" (PDF). www.****e-indices.com. 2015-06-19. Retrieved...
- of
therapies for the
treatment of haemophilia.
Bioverativ competes with
Baxalta (acquired by
Shire Plc in 2016),
Pfizer and Novo Nordisk. The
company traded...
-
Eastern European headquarters in Vienna,
including Hewlett-Packard, Henkel,
Baxalta, and Siemens.
Annually since 2004,
approximately 8,300 new
companies have...
- ****an. In 2015,
Baxter split-off its
haemophilia sector to
create Baxalta. In 2016
Baxalta was
acquired by
Shire plc for $32bn.
Immuno AG:
Baxter purchased...
-
technology Enhanze to
other biopharmaceutical companies,
including Roche,
Baxalta, Pfizer, Janssen, AbbVie,
Bristol Myers Squibb and Lilly.
Since January...
